Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncology Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Germ Cell Tumor
• Choroid Plexus Tumor
• Craniopharyngioma
• Ependymoma
• Medulloblastoma
• Meningioma
• Neuroblastoma
• Oligodendroglioma

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor | Phase 2 | Status: COMPLETED